|
CARDIZEM
|
6505-01-322-6500
|
Usp Diltiazem Tablets |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
|
CARDIZEM TABLETS
|
6505-01-322-6500
|
Usp Diltiazem Tablets |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
|
NDC00088-1771-55
|
6505-01-322-6500
|
Usp Diltiazem Tablets |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
|
CARDIZEM
|
6505-01-322-6500
|
Usp Diltiazem Tablets |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
|
CARDIZEM TABLETS
|
6505-01-322-6500
|
Usp Diltiazem Tablets |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
|
NDC00088-1771-55
|
6505-01-322-6500
|
Usp Diltiazem Tablets |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
|
CARDIZEM
|
6505-01-322-6501
|
Usp Diltiazem Tablets |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
|
CARDIZEM TABLETS
|
6505-01-322-6501
|
Usp Diltiazem Tablets |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
|
NDC00088-1772-55
|
6505-01-322-6501
|
Usp Diltiazem Tablets |
Sanofi-aventis U.s. Inc
|
|
Quote
|
|
NDC00088-1772-55
|
6505-01-322-6501
|
Usp Diltiazem Tablets |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
|
NDC51079-0540-43
|
6505-01-322-8025
|
Suspension Activated Charcoal |
Mylan Institutional Inc.
|
|
Quote
|
|
NDC51079-0540-43
|
6505-01-322-8025
|
Suspension Activated Charcoal |
Mylan Institutional Inc.
|
|
Quote
|
|
NDC51079-0540-43
|
6505-01-322-8025
|
Suspension Activated Charcoal |
Mylan Institutional Inc.
|
|
Quote
|
|
NDC51079-0540-43
|
6505-01-322-8025
|
Suspension Activated Charcoal |
Mylan Institutional Inc.
|
|
Quote
|
|
NDC51079-0540-43
|
6505-01-322-8025
|
Suspension Activated Charcoal |
Mylan Institutional Inc.
|
|
Quote
|
|
TOLECTIN 600
|
6505-01-322-8539
|
Usp Tolmetin Sodium Tablets |
Mcneil Lab Inc
|
|
Quote
|
|
TOLECTIN TABLETS
|
6505-01-322-8539
|
Usp Tolmetin Sodium Tablets |
Mcneil Lab Inc
|
|
Quote
|
|
NDC00045-0416-60
|
6505-01-322-8539
|
Usp Tolmetin Sodium Tablets |
Mcneil Pharmaceutical Co
|
|
Quote
|
|
NDC00045-0416-60
|
6505-01-322-8539
|
Usp Tolmetin Sodium Tablets |
Mcneil Lab Inc
|
|
Quote
|
|
CARAFATE
|
6505-01-322-9347
|
Sucralfate Tablets |
Sanofi-aventis U.s. Inc
|
|
Quote
|
|
CARAFETE TABLETS
|
6505-01-322-9347
|
Sucralfate Tablets |
Sanofi-aventis U.s. Inc
|
|
Quote
|
|
NDC00088-1712-53
|
6505-01-322-9347
|
Sucralfate Tablets |
Sanofi-aventis U.s. Inc
|
|
Quote
|
|
NDC58914-0171-21
|
6505-01-322-9347
|
Sucralfate Tablets |
Axcan Pharma Us Inc.
|
|
Quote
|
|
CARAFATE
|
6505-01-322-9347
|
Sucralfate Tablets |
Sanofi-aventis U.s. Inc
|
|
Quote
|
|
CARAFETE TABLETS
|
6505-01-322-9347
|
Sucralfate Tablets |
Sanofi-aventis U.s. Inc
|
|
Quote
|
|
NDC00088-1712-53
|
6505-01-322-9347
|
Sucralfate Tablets |
Sanofi-aventis U.s. Inc
|
|
Quote
|
|
NDC58914-0171-21
|
6505-01-322-9347
|
Sucralfate Tablets |
Axcan Pharma Us Inc.
|
|
Quote
|
|
NDC00006-0963-58
|
6505-01-322-9348
|
Usp Famotidine Tablets |
Merck Sharp & Dohme Corp.
|
|
Quote
|
|
NDC00006-0963-58
|
6505-01-322-9348
|
Usp Famotidine Tablets |
Merck Sharp & Dohme Corp.
|
|
Quote
|
|
08-6610
|
6505-01-323-2630
|
Concentrat Hemodialysis Solution |
National Medical Care
|
|
Quote
|
|
RMS
|
6505-01-323-2648
|
Morphine Sulfate Suppositories |
Upsher-smith Laboratories, Inc.
|
|
Quote
|
|
RMS SUPPOSITORIES
|
6505-01-323-2648
|
Morphine Sulfate Suppositories |
Upsher-smith Laboratories, Inc.
|
|
Quote
|
|
NDC00245-0162-12
|
6505-01-323-2648
|
Morphine Sulfate Suppositories |
Upsher-smith Laboratories, Inc.
|
|
Quote
|
|
NDC00054-8777-05
|
6505-01-323-2648
|
Morphine Sulfate Suppositories |
Boehringer Ingelheim Roxane, Inc.
|
|
Quote
|
|
FORTAZ
|
6505-01-323-2649
|
Ceftazidime Sodium In Dextrose I |
Glaxo Wellcome Inc
|
|
Quote
|
|
FORTAZ INJECTION
|
6505-01-323-2649
|
Ceftazidime Sodium In Dextrose I |
Glaxo Wellcome Inc
|
|
Quote
|
|
NDC00173-0413-00
|
6505-01-323-2649
|
Ceftazidime Sodium In Dextrose I |
Glaxo Wellcome Inc
|
|
Quote
|
|
2G3536
|
6505-01-323-2649
|
Ceftazidime Sodium In Dextrose I |
Baxter Healthcare Corp
|
|
Quote
|
|
2G558
|
6505-01-323-2649
|
Ceftazidime Sodium In Dextrose I |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
RMS
|
6505-01-323-2650
|
Morphine Sulfate Suppositories |
Upsher-smith Laboratories, Inc.
|
|
Quote
|
|
NDC00245-0163-12
|
6505-01-323-2650
|
Morphine Sulfate Suppositories |
Upsher-smith Laboratories, Inc.
|
|
Quote
|
|
NDC00054-8778-05
|
6505-01-323-2650
|
Morphine Sulfate Suppositories |
Boehringer Ingelheim Roxane, Inc.
|
|
Quote
|
|
A90E04
|
6505-01-323-4605
|
Usp Levothyroxine Sodium Tablets |
Department of the Army
|
|
Quote
|
|
SYNTHROID
|
6505-01-323-4605
|
Usp Levothyroxine Sodium Tablets |
Abbott Laboratories Inc.
|
|
Quote
|
|
SYNTHROID TABLETS
|
6505-01-323-4605
|
Usp Levothyroxine Sodium Tablets |
Abbott Laboratories Inc.
|
|
Quote
|
|
NDC00048-1130-05
|
6505-01-323-4605
|
Usp Levothyroxine Sodium Tablets |
Abbott Laboratories Inc.
|
|
Quote
|
|
A90E04
|
6505-01-323-4605
|
Usp Levothyroxine Sodium Tablets |
Department of the Army
|
|
Quote
|
|
SYNTHROID
|
6505-01-323-4605
|
Usp Levothyroxine Sodium Tablets |
Abbott Laboratories Inc.
|
|
Quote
|
|
SYNTHROID TABLETS
|
6505-01-323-4605
|
Usp Levothyroxine Sodium Tablets |
Abbott Laboratories Inc.
|
|
Quote
|
|
NDC00048-1130-05
|
6505-01-323-4605
|
Usp Levothyroxine Sodium Tablets |
Abbott Laboratories Inc.
|
|
Quote
|
|
NDC10432-0322-02
|
6505-01-323-4606
|
Usp Niacin Tablets |
Freeda Pharmaceutical
|
|
Quote
|
|
NDC00003-2240-11
|
6505-01-323-5253
|
Aztreonam In Dextrose Injection |
Bristol-myers Squibb Company
|
|
Quote
|
|
NDC00003-2240-11
|
6505-01-323-5253
|
Aztreonam In Dextrose Injection |
Bristol-myers Squibb Company
|
|
Quote
|
|
NDC00003-2240-11
|
6505-01-323-5253
|
Aztreonam In Dextrose Injection |
Bristol-myers Squibb Company
|
|
Quote
|
|
NDC00003-2230-11
|
6505-01-323-5254
|
Aztreonam In Dextrose Injection |
Bristol-myers Squibb Co Inc
|
|
Quote
|
|
NDC00003-2230-11
|
6505-01-323-5254
|
Aztreonam In Dextrose Injection |
Bristol-myers Squibb Co Inc
|
|
Quote
|
|
NDC00003-2230-11
|
6505-01-323-5254
|
Aztreonam In Dextrose Injection |
Bristol-myers Squibb Co Inc
|
|
Quote
|
|
90-0597
|
6505-01-323-5255
|
Usp Cimetidine Tablets |
Defense Logistics Agency
|
|
Quote
|
|
NDC00093-8204-05
|
6505-01-323-5255
|
Usp Cimetidine Tablets |
Teva Pharmaceuticals Usa, Inc.
|
|
Quote
|
|
90-0597
|
6505-01-323-5255
|
Usp Cimetidine Tablets |
Defense Logistics Agency
|
|
Quote
|
|
NDC00093-8204-05
|
6505-01-323-5255
|
Usp Cimetidine Tablets |
Teva Pharmaceuticals Usa, Inc.
|
|
Quote
|
|
90-0597
|
6505-01-323-5255
|
Usp Cimetidine Tablets |
Defense Logistics Agency
|
|
Quote
|
|
NDC00093-8204-05
|
6505-01-323-5255
|
Usp Cimetidine Tablets |
Teva Pharmaceuticals Usa, Inc.
|
|
Quote
|
|
90-0598
|
6505-01-323-5256
|
Usp Cimetidine Tablets |
Defense Logistics Agency
|
|
Quote
|
|
NDC60505-0019-04
|
6505-01-323-5256
|
Usp Cimetidine Tablets |
Apotex Corp.
|
|
Quote
|
|
90-0598
|
6505-01-323-5256
|
Usp Cimetidine Tablets |
Defense Logistics Agency
|
|
Quote
|
|
NDC60505-0019-04
|
6505-01-323-5256
|
Usp Cimetidine Tablets |
Apotex Corp.
|
|
Quote
|
|
90-0598
|
6505-01-323-5256
|
Usp Cimetidine Tablets |
Defense Logistics Agency
|
|
Quote
|
|
NDC60505-0019-04
|
6505-01-323-5256
|
Usp Cimetidine Tablets |
Apotex Corp.
|
|
Quote
|
|
MARINOL
|
6505-01-323-5259
|
Usp Dronabinol Capsules |
Boehringer Ingelheim Roxane, Inc.
|
|
Quote
|
|
MARINOL CAPSULES
|
6505-01-323-5259
|
Usp Dronabinol Capsules |
Boehringer Ingelheim Roxane, Inc.
|
|
Quote
|
|
NDC54868-3084-00
|
6505-01-323-5259
|
Usp Dronabinol Capsules |
Medical and Safety Group Inc
|
|
Quote
|
|
NDC00054-8541-11
|
6505-01-323-5259
|
Usp Dronabinol Capsules |
Boehringer Ingelheim Roxane, Inc.
|
|
Quote
|
|
Unknown
|
6505-01-323-6434
|
Concentrat Hemodialysis Solution |
Unknown
|
|
Quote
|
|
NDC53489-0551-01
|
6505-01-323-6557
|
Propafenone Hydrochloride Tablet |
Mutual Pharmaceutical Company, Inc.
|
|
Quote
|
|
NDC00603-5448-21
|
6505-01-323-6557
|
Propafenone Hydrochloride Tablet |
Generics Bidco I, Llc
|
|
Quote
|
|
51079-0278-20
|
6505-01-323-6575
|
Propranolol Hydrochloride Tablet |
Mylan Institutional Inc.
|
|
Quote
|
|
A90E038
|
6505-01-323-6575
|
Propranolol Hydrochloride Tablet |
Department of the Army
|
|
Quote
|
|
NDC51079-0278-20
|
6505-01-323-6575
|
Propranolol Hydrochloride Tablet |
Mylan Institutional Inc.
|
|
Quote
|
|
NDC00364-0757-90
|
6505-01-323-6575
|
Propranolol Hydrochloride Tablet |
Schein Pharmaceutical Inc
|
|
Quote
|
|
NDC00182-1813-89
|
6505-01-323-6575
|
Propranolol Hydrochloride Tablet |
Goldline Laboratories Inc.
|
|
Quote
|
|
73927
|
6505-01-323-6575
|
Propranolol Hydrochloride Tablet |
Mylan Institutional Inc.
|
|
Quote
|
|
NDC00074-6028-01
|
6505-01-323-6576
|
Usp Morphine Sulfate Injection |
Abbott Laboratories
|
|
Quote
|
|
NDC49702-0213-05
|
6505-01-324-3729
|
Usp Zidovudine Injection |
Viiv Healthcare Company
|
|
Quote
|
|
NDC49702-0212-48
|
6505-01-324-3730
|
Zidovudine Syrup |
Viiv Healthcare Company
|
|
Quote
|
|
NDC59772-7045-40
|
6505-01-324-5224
|
Usp Captopril Tablets |
Bristol-myers Co
|
|
Quote
|
|
EPOGEN
|
6505-01-324-5226
|
Epoetin Alfa Injection |
Amgen Inc.
|
|
Quote
|
|
NDC55513-0267-10
|
6505-01-324-5226
|
Epoetin Alfa Injection |
Amgen Inc.
|
|
Quote
|
